#SaiParenteralsLimited

SAI Parenteral’s Ltd. Acquires Australia’s Noumed Pharmaceuticals for INR 125 crore

HYDERABAD, INDIA, DECEMBER 1, 2025 (GPN/ SACHIN MURDESHWAR 📞 8108510506)— SAI Parenteral’s Limited (SPL), a diversified pharmaceutical formulation company, today announced the acquisition of a 74.6% controlling stake in Noumed Pharmaceuticals Pty Ltd, an Adelaide-based…


Telangana-based Sai Parenteral’s Files DRHP for IPO

DRHP Link:  https://www.bseindia.com/corporates/download/367498/IPO%20Prior/DRHP_20250930232833.pdf NATIONAL, 5th OCTOBER, 2025 (GPN/ SACHIN MURDESHWAR  8108510506) – Telegana-based Sai Parenteral’s has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) for its proposed Initial Public…